IDEAYA Biosciences Competitors and Similar CompaniesClear all

Galectin Therapeutics's competitors and similar companies include Merrimack Pharmaceuticals and Signpath Pharma.

	Galectin Therapeutics Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.	Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.	Signpath Pharma SignPath Pharma is a biotechnology company that develops products to treat cancer and mitigate drug-induced cardiac arrhythmia.
Founding Date	Founding Date 2001	Founding Date 2000	Founding Date 2006
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Norcross, US HQ	Locations Cambridge, US HQ	Locations Sandy, US HQ
Employees	Employees 717% increase	Employees 2763% decrease	Employees 11
Valuation ($)	Valuation ($) 155.1 m	Valuation ($) 223.7 m	Valuation ($) N/A
Financial
Net income	Net income ($30.8m) (FY, 2025)	Net income ($1.2m) (FY, 2023)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 79.4m	Total funding raised $ 5.3m